Total Payments
$195,281
2024 Payments
$2,243
Companies
74
Transactions
1,991
Medicare Patients
6,096
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$148,930 (76.3%)
Food & Beverage$31,969 (16.4%)
Travel$8,495 (4.4%)
Consulting$5,352 (2.7%)
Education$436.04 (0.2%)
Gifts$100.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $148,930 | 108 | 76.3% |
| Food and Beverage | $31,969 | 1,767 | 16.4% |
| Travel and Lodging | $8,495 | 72 | 4.4% |
| Consulting Fee | $5,352 | 7 | 2.7% |
| Education | $436.04 | 36 | 0.2% |
| Gift | $100.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $39,037 | 168 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $37,511 | 149 | $0 (2024) |
| Allergan, Inc. | $32,610 | 138 | $0 (2021) |
| ABBVIE INC. | $24,751 | 155 | $0 (2023) |
| GlaxoSmithKline, LLC. | $20,467 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13,149 | 233 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $4,367 | 14 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $3,683 | 17 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,096 | 30 | $0 (2020) |
| Mannkind Corporation | $2,116 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,243 | 118 | AstraZeneca Pharmaceuticals LP ($430.12) |
| 2023 | $2,287 | 141 | ABBVIE INC. ($349.29) |
| 2022 | $3,659 | 107 | ABBVIE INC. ($2,145) |
| 2021 | $21,747 | 153 | GlaxoSmithKline, LLC. ($8,791) |
| 2020 | $41,390 | 220 | Allergan, Inc. ($22,063) |
| 2019 | $12,360 | 267 | Janssen Pharmaceuticals, Inc ($5,317) |
| 2018 | $31,709 | 372 | SANOFI-AVENTIS U.S. LLC ($11,761) |
| 2017 | $79,886 | 613 | SANOFI-AVENTIS U.S. LLC ($25,230) |
All Payment Transactions
1,991 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Pulmonology | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $141.67 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $6.65 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Psychiatry/Psychology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,903 | 6,223 | $1.0M | $424,539 |
| 2022 | 25 | 1,303 | 4,911 | $688,997 | $278,772 |
| 2021 | 25 | 1,349 | 3,370 | $409,531 | $207,563 |
| 2020 | 21 | 1,541 | 4,191 | $628,286 | $241,337 |
Total Patients
6,096
Total Services
18,695
Medicare Billing
$1.2M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 203 | 746 | $183,321 | $68,742 | 37.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 179 | 727 | $181,750 | $68,316 | 37.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 649 | $63,602 | $44,759 | 70.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 532 | $106,100 | $33,016 | 31.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 63 | 459 | $69,221 | $29,533 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 282 | $42,300 | $29,167 | 69.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 393 | $41,265 | $28,061 | 68.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 114 | 272 | $40,800 | $21,103 | 51.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 86 | $30,100 | $12,997 | 43.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 66 | 75 | $17,150 | $11,741 | 68.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 30 | 79 | $15,800 | $10,315 | 65.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 53 | 191 | $24,044 | $8,240 | 34.3% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 13 | 253 | $37,950 | $7,442 | 19.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 72 | 96 | $19,200 | $6,820 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 51 | $15,300 | $5,616 | 36.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Facility | 2023 | 50 | 214 | $42,700 | $5,506 | 12.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Facility | 2023 | 48 | 206 | $18,525 | $5,300 | 28.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 45 | 100 | $10,484 | $4,786 | 45.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 87 | $8,118 | $4,407 | 54.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 78 | $7,938 | $3,315 | 41.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 38 | 88 | $11,662 | $2,625 | 22.5% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Facility | 2023 | 55 | 60 | $4,500 | $2,259 | 50.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 16 | 17 | $2,550 | $1,916 | 75.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $2,260 | $1,726 | 76.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $4,200 | $1,683 | 40.1% |
About Dr. Kumar Ramdas, M.D
Dr. Kumar Ramdas, M.D is a Internal Medicine healthcare provider based in Maplewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780663898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kumar Ramdas, M.D has received a total of $195,281 in payments from pharmaceutical and medical device companies, with $2,243 received in 2024. These payments were reported across 1,991 transactions from 74 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($148,930).
As a Medicare-enrolled provider, Ramdas has provided services to 6,096 Medicare beneficiaries, totaling 18,695 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Maplewood, NJ
- Active Since 01/17/2006
- Last Updated 11/26/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780663898
Products in Payments
- INVOKANA (Drug) $37,601
- SOLIQUA (Drug) $25,740
- UBRELVY (Drug) $23,368
- TRELEGY ELLIPTA (Drug) $20,149
- VRAYLAR (Drug) $13,434
- TOUJEO (Drug) $11,220
- Creon (Drug) $10,093
- BEVESPI AEROSPHERE (Drug) $9,865
- Trintellix (Drug) $6,897
- LINZESS (Drug) $4,183
- DUZALLO (Drug) $3,562
- CREON (Drug) $2,822
- FARXIGA (Drug) $2,250
- AFREZZA (Drug) $2,116
- JARDIANCE (Drug) $1,500
- XARELTO (Drug) $1,359
- LATUDA (Drug) $957.86
- ENTRESTO (Drug) $629.86
- JANUVIA (Drug) $593.75
- TRULICITY (Drug) $567.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Maplewood
Dr. Khalil Kaid
Internal Medicine — Payments: $28,894
Internal Medicine $28,894
Dr. Gaurang Shah, Md, MD
Internal Medicine — Payments: $16,855
Internal Medicine $16,855
Dr. Richard Solomon, M.d, M.D
Internal Medicine — Payments: $12,811
Internal Medicine $12,811
Chirag Patel, M.d, M.D
Internal Medicine — Payments: $9,123
Internal Medicine $9,123
Dr. Samuel Duncan, M.d, M.D
Internal Medicine — Payments: $2,863
Internal Medicine $2,863
Dr. Pamela Grover, M.d, M.D
Internal Medicine — Payments: $2,305
Internal Medicine $2,305